全文获取类型
收费全文 | 13909篇 |
免费 | 848篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 263篇 |
妇产科学 | 158篇 |
基础医学 | 1771篇 |
口腔科学 | 346篇 |
临床医学 | 994篇 |
内科学 | 3399篇 |
皮肤病学 | 230篇 |
神经病学 | 823篇 |
特种医学 | 715篇 |
外科学 | 2696篇 |
综合类 | 46篇 |
一般理论 | 3篇 |
预防医学 | 302篇 |
眼科学 | 166篇 |
药学 | 876篇 |
中国医学 | 24篇 |
肿瘤学 | 1886篇 |
出版年
2023年 | 165篇 |
2022年 | 247篇 |
2021年 | 587篇 |
2020年 | 292篇 |
2019年 | 400篇 |
2018年 | 460篇 |
2017年 | 383篇 |
2016年 | 408篇 |
2015年 | 402篇 |
2014年 | 458篇 |
2013年 | 482篇 |
2012年 | 796篇 |
2011年 | 875篇 |
2010年 | 458篇 |
2009年 | 367篇 |
2008年 | 664篇 |
2007年 | 672篇 |
2006年 | 601篇 |
2005年 | 594篇 |
2004年 | 552篇 |
2003年 | 528篇 |
2002年 | 516篇 |
2001年 | 336篇 |
2000年 | 325篇 |
1999年 | 348篇 |
1998年 | 178篇 |
1997年 | 134篇 |
1996年 | 130篇 |
1995年 | 85篇 |
1994年 | 95篇 |
1993年 | 71篇 |
1992年 | 214篇 |
1991年 | 184篇 |
1990年 | 167篇 |
1989年 | 153篇 |
1988年 | 185篇 |
1987年 | 154篇 |
1986年 | 119篇 |
1985年 | 137篇 |
1984年 | 99篇 |
1983年 | 88篇 |
1979年 | 72篇 |
1978年 | 57篇 |
1977年 | 44篇 |
1976年 | 41篇 |
1974年 | 44篇 |
1973年 | 43篇 |
1972年 | 52篇 |
1971年 | 39篇 |
1969年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Hiroto Kinoshita Hitomi Nishioka Aya Ikeda Kyoko Ikoma Yoichi Sameshima Hidehisa Ohi Mizuki Tatsuno Junka Kouyama Chiaki Kawamoto Tomohiro Mitsui Yuko Tamura Yu Hashimoto Masashi Nishio Tsuyoshi Ogashiwa Yusuke Saigusa Shin Maeda Hideaki Kimura Reiko Kunisaki Kazuhiko Koike 《Journal of gastroenterology and hepatology》2019,34(11):1929-1939
5.
6.
7.
Marie Ohata Susumu Fujiwara Ai Yoshioka Hiroshi Nagai Shintaro Sugita Nozomi Yamano Yusuke Inoue Chikako Nishigori 《Pediatric dermatology》2019,36(6):997-998
Fibroblastic connective tissue nevus (FCTN) is a benign cutaneous mesenchymal lesion characterized by proliferation of CD34‐positive fibroblastic/myofibroblastic spindle‐shaped cells. We report a case of agminated FCTN on the right lower abdomen of a 1‐year‐old boy. 相似文献
8.
Y. Kuroda H. Takashima A. Ikeda C. Endo R. Neshige R. Kakigi H. Shibasaki 《Journal of neurology》1991,238(6):309-314
Summary Fourteen patients with HTLV-1-associated myelopathy were treated with high-dose intravenous gammaglobulin (IVGG). Ten received 10 g/day of IVGG and 4 received 400 mg/kg of body-weight/day of IVGG for 5 consecutive days. Improvement of spastic paraparesis was observed in 10 within 7 days of the commencement of IVGG. The therapeutic effects were sustained for more than 3 weeks in some patients. There were no side effects. Analysis of factors of relevance to the clinical improvement with IVGG showed that the beneficial response was preferentially found in patients having a high CSF titre of anti-HTLV-I antibodies, a high CSF IgG level and a marked brain MRI abnormality. 相似文献
9.
Prolidase was highly purified from human liver and erythrocytes. NaDodSO4/acrylamide gel electrophoresis revealed that these preparations contained a major protein with MW = 56,000. The mass of prolidase was estimated on gel filtration to be MW = 97,000, for both enzyme preparations. A monoclonal antibody was raised against the liver enzyme and a specific antiserum against the erythrocyte enzyme. The monoclonal antibody (EP-2) recognized prolidase from erythrocytes and liver, in equal proportions. The antiserum also recognized the enzyme from erythrocytes and liver. Immunoprecipitation studies with these antibodies suggested only a single species of prolidase in erythrocytes and liver. Using an immobilized monoclonal antibody (EP-2) as an immunoadsorbent, prolidase was partially purified from crude extracts, and the protein of the partially purified enzyme was identified by immunoblotting using antiserum. A protein band with a MW = 56,000 was demonstrated specifically when crude extracts from the liver and erythrocytes were examined using NaDodSO4/acrylamide gel electrophoresis. The subunit protein was absent in erythrocytes from a patient with prolidase deficiency. We propose that the absence of the subunit is one cause of the prolidase deficiency. 相似文献
10.
The correlation between the treadmill exercise test results and the hemodynamic data of 152 patients with previous myocardial infarction were investigated. The patients were classified into 4 groups as follows: H1 left ventricular end-diastolic pressure (LVEDP) less than or equal to 12 mmHg and cardiac index (CI) greater than or equal to 3.0 L/min/m2; H2 LVEDP greater than 12 mmHg and CI greater than or equal to 3.0 L/min/m2; H3 LVEDP less than or equal to 12 mmHg and CI less than 3.0 L/min/m2; and H4 LVEDP greater than 12 mmHg and CI less than 3.0 L/min/m2. The duration of the exercise was significantly shortened for group H4 than group H1 (p less than 0.01). The maximal ST segment elevation (mSTe) was significantly increased for group H3 and group H4, versus group H1 (p less than 0.05). The number of ST segment elevations and mSTe/maximal heart rate were significantly increased for group H3 (p less than 0.05) and group H4 (p less than 0.01) versus group H1. The incidence of exercise-induced premature ventricular contractions (PVCs) was significantly increased in group H3 and group H4, versus group H1 (p less than 0.05). There were no significant differences in the maximal heart rate, double product, and ST segment depression among the 4 groups. Our data indicate that the groups with impaired left ventricular functions tend to decrease the duration of the exercise and to increase ST segment elevation and PVC frequencies during exercise. 相似文献